Biosimilars and Biologics

Globalization of Biosimilars tells us about the generic drugs impact on global biosimilars market, Cost and risk management, and Adopting innovative mechanisms such as risk-sharing arrangement, and European market for biosimilars. The global market scenario with the launch of first biosimilars in the market forecasts some radical changes. Globalization of Biosimilars will look upon such key concerns which are witnessed by the global pharma market and that are coming up with the subsequent launch of the other biosimilars and biologics.

• Biosimilar Multimodal Techniques
• Biosimilar Electrophoresis and Formulation
• Biosimilar GMP Protein Analysis
• Supply Chain Challenges Before Biosimilars